» Articles » PMID: 15814238

Alginate Rafts and Their Characterisation

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2005 Apr 9
PMID 15814238
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Alginate/antacid anti-reflux preparations are designed to provide symptom relief by forming a physical barrier on top of the stomach contents in the form of a neutral floating gel or raft. This study tested the in vitro effectiveness of a range of liquid products in forming rafts that were cohesive, buoyant, voluminous, resistant to reflux and durable under conditions of movement (resilient). The products tested had a wide range of acid neutralising capacities (ANCs). It was found that products with a high ANC and no calcium ion source formed rafts of low strength, weight and volume, which appeared more as floating precipitates than coherent gels. Products with a high ANC and a calcium ion source formed medium strength, weight and volume rafts. Products with a low ANC formed strong coherent rafts with medium to large weight and volume, and those with low ANC and a calcium ion source formed the strongest rafts. Products with stronger rafts were found to be more resilient and more resistant to reflux in an in vitro reflux model. Significant overall differences in raft buoyancy were found between products forming coherent rafts but these could not be related to the product formulation or amount of available carbon dioxide.

Citing Articles

Oral co-polymeric raft-forming nano gels for targeted empagliflozin delivery against stomach cancer (SGC7901).

Alhakamy N, Abdullah S, Md S, Ansari A, Bhattamisra S, Ibrahim I Heliyon. 2024; 10(13):e34074.

PMID: 39071709 PMC: 11279758. DOI: 10.1016/j.heliyon.2024.e34074.


Expanding the Manufacturing Approaches for Gastroretentive Drug Delivery Systems with 3D Printing Technology.

Turac I, Porfire A, Iurian S, Crisan A, Casian T, Iovanov R Pharmaceutics. 2024; 16(6).

PMID: 38931911 PMC: 11207633. DOI: 10.3390/pharmaceutics16060790.


Development of raft-forming liquid formulations loaded with ginger extract-solid dispersion for treatment of gastric ulceration.

Matchimabura N, Praparatana R, Issarachot O, Oungbho K, Wiwattanapatapee R Heliyon. 2024; 10(11):e31803.

PMID: 38841494 PMC: 11152664. DOI: 10.1016/j.heliyon.2024.e31803.


Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?.

Namikawa K, Bjornsson E Int J Mol Sci. 2024; 25(10).

PMID: 38791497 PMC: 11122117. DOI: 10.3390/ijms25105459.


Development of Oral In Situ Gelling Liquid Formulations of Garcinia Extract for Treating Obesity.

Fungfoung K, Praparatana R, Issarachot O, Wiwattanapatapee R Gels. 2023; 9(8).

PMID: 37623115 PMC: 10453886. DOI: 10.3390/gels9080660.